在患有严重阻塞性睡眠呼吸暂停综合征的肥胖患者中对运动能力的横截面研究
Shengrui Mei1, Yue Zhou1, Wenjun Wu2
1Department of Rehabilitation Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China.
Frontiers in physiology
|September 10, 2025
概括
患有严重阻塞性睡眠呼吸暂停综合征 (OSAS) 的肥胖患者表现出运动能力降低,呼吸暂停-呼吸暂停指数 (AHI) 对心肺功能产生负面影响. 心肺运动测试 (CPET) 可以识别这些下降,促使早期干预.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 睡眠医学 睡眠医学
- 运动生理学 运动生理学
背景情况:
- 肥胖是一种与各种并发症相关的重大健康问题.
- 严重阻塞性睡眠呼吸暂停综合征 (OSAS) 是肥胖个体的常见并发症.
- 严重的OSAS对肥胖患者的运动能力的影响需要进一步阐明.
研究的目的:
- 通过心肺运动测试 (CPET) 调查患有严重OSAS的肥胖患者的运动能力.
- 评估肥胖患者的呼吸暂停-低呼吸指数 (AHI) 和心肺运动参数之间的相关性.
- 确定CPET在评估该人群中的功能限制方面的有用性.
主要方法:
- 一项横截面研究比较了三个组:简单的肥胖,严重的肥胖OSAS和健康的对照组.
- 所有参与者都接受了多睡眠和心肺运动测试 (CPET).
- 统计分析,包括相关性和回归,用于比较组,并评估AHI和CPET/多睡眠学数据之间的关系.
主要成果:
- 与对照组相比,患有严重OSAS的肥胖患者在睡眠参数 (AHI,睡眠效率,SaO2) 中表现出显著差异.
- 虽然峰值氧气消耗 (VO2峰值) 没有显著差异,但在严重的OSAS组中,调整后的VO2峰值 (%Pred,/kg) 和呼吸器效率 (VO2/HRmax) 受到损害.
- 呼吸暂停-呼吸暂停指数 (AHI) 与多个CPET指标负相关,包括VO2峰%Pred,VO2峰/kg和呼吸器效率,即使经过对混因素进行调整.
结论:
- 严重的OSAS显著加剧了肥胖患者运动能力的下降.
- 运动限制的严重程度与AHI值正相关.
- 在患有OSAS的肥胖患者中,CPET是评估心肺功能的一个有价值的工具,指导早期干预.
相关概念视频
01:21Sleep Apnea
484
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
484
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
01:21Drug Dosing: Obese Patients
226
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
226
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
01:22Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K